Triochem Products share price

BSE: 512101Pharmaceuticals & Biotechnology

Triochem Products Ltd. · Face value ₹10 · Listed Jun 1985

Last traded ₹17.40 on 24 Sep 2015

Latest announcements

Routine notices left out.

  1. Oct 2026

Share price history

Daily closes since Sep 2008, adjusted for splits and bonuses

Daily close, ₹ per share

Q1 results, quarter to Jun 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
−₹0.04 Cr
Net profit
₹0.09 Cr−98.9% on the quarter before
Earnings per share
₹3.87−98.9% on the quarter before

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income+0.2
  7. Finance costs0.0
  8. Profit before tax0.1
  9. Tax0.0
  10. Net profit0.1

Triochem Products results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
0−1.0Sep 230−0.2Dec 2300.3Mar 240−0.1Jun 2400.0Sep 2400.1Dec 240−0.5Mar 2500.0Jun 250−0.2Sep 250−0.1Dec 2508.3Mar 2600.1Jun 26
Peak revenue ₹0.00 Cr, quarter to Sep 2023A loss in 8 of the 12 quarters shown

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Filed 26 MayJun 2023Q1Filed 14 AugSep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Filed 13 NovDec 2024Q3Filed 12 FebMar 2025Q4Jun 2025Q1Filed 14 AugSep 2025Q2Filed 12 NovDec 2025Q3Filed 13 FebMar 2026Q4Filed 29 MayJun 2026Q1Filed 14 Aug
Revenue from operations3.33.12.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
3.12.31.80.30.40.30.30.30.30.20.30.30.30.60.30.40.40.40.20.0
Materials and goods bought2.72.01.50.00.00.00.00.00.00.00.00.00.00.00.10.00.00.00.00.0
Employee costs0.10.20.10.10.10.10.10.10.10.10.10.20.10.30.10.10.10.10.10.0
Other expenses0.20.20.20.20.20.20.20.10.20.10.20.20.10.30.10.20.30.20.10.0
Operating profit before depreciation0.20.80.7−0.3−0.4−0.3−0.3−0.3−0.3−0.2−0.3−0.3−0.3−0.6−0.3−0.4−0.4−0.4−0.20.0
Operating margin6.4%24.6%27.1%–––––––––––––––––
Depreciation and amortisation0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other income0.10.00.20.10.10.00.10.10.10.00.80.20.30.50.30.20.30.20.10.2
Finance costs0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.0
Profit before one-off items and tax0.30.80.9−0.3−0.3−0.3−0.3−0.1−0.3−0.20.5−0.10.0−0.20.0−0.2−0.1−0.2−0.20.1
One-off items0.00.00.00.00.00.00.00.0−1.20.00.00.00.00.00.00.00.00.011.20.0
Profit before tax0.30.80.9−0.3−0.3−0.3−0.3−0.1−1.4−0.20.5−0.10.0−0.20.0−0.2−0.1−0.211.00.1
0.10.20.2−0.1−0.1−0.1−0.10.0−0.40.00.10.00.0−0.30.4−0.10.00.02.70.0
Tax rate26.4%23.1%26.7%–––––––27.9%–––––––24.2%23.5%
Net profit0.20.60.6−0.2−0.2−0.2−0.2−0.1−1.0−0.20.3−0.10.00.1−0.50.0−0.2−0.18.30.1
Other comprehensive income0.00.00.00.0−0.40.5−0.70.70.61.90.90.90.2−0.3−0.50.9−0.5−0.3−1.11.0
Total comprehensive income0.20.60.6−0.2−0.60.3−0.90.6−0.41.71.20.80.2−0.2−0.90.9−0.7−0.47.21.1
Net margin6.2%19.1%25.9%–––––––––––––––––
Earnings per share₹8.31₹24.27₹25.87−₹7.87−₹10.03−₹10.11−₹8.11−₹4.40−₹41.85−₹8.34₹13.24−₹3.20−₹1.49₹3.60−₹18.44−₹1.25−₹7.86−₹5.38₹339.83₹3.87
Earnings per share in rupees, restated for later splits and bonuses.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
180.6Mar 17362.6Mar 18120.75.8Mar 19203.42.5Mar 2014−0.40Mar 218.81.30Mar 220−0.90Mar 230−1.00Mar 240−0.40Mar 2508.00Mar 26
Peak revenue ₹36 Cr, year to Mar 2018; lowest ₹0.00 Cr, year to Mar 2023Back to profit in the year to Mar 2026, ₹7.97 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin
22.4%−3.4%5.5%10.7%13.3%22.4%−3.4%15.1%3.2%7.2%6.0%17.0%−3.2%15.0%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs−0.5
  3. Other expenses−0.9
  4. Operating profit−1.4
  5. Depreciation0.0
  6. Other income+0.9
  7. One-off items+11
  8. Finance costs−0.1
  9. Profit before tax11
  10. Tax−2.5
  11. Net profit8.0

What the company owns

  • Cash and bank₹12 Cr
  • Plant, investments and other assets₹9 Cr

What pays for it: net worth and liabilities

  • Net worth₹21 Cr
  • Other liabilities₹0 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 26 MayMar 2024Mar 2025Mar 2026Filed 29 MayJun 2026Twelve monthsFiled 14 Aug
Revenue from operations18.135.512.420.013.98.80.00.00.00.00.0
17.131.710.715.514.47.51.31.11.21.41.1
Materials and goods bought15.228.88.413.612.66.30.00.00.10.00.0
Employee costs0.7–0.70.80.70.50.50.50.60.50.4
Other expenses1.2–1.61.11.10.70.80.60.60.90.7
Operating profit before depreciation1.03.81.64.5−0.51.3−1.3−1.1−1.2−1.4−1.1
Operating margin5.5%10.7%13.3%22.4%−3.4%15.1%–––––
Materials, % of revenue84.0%–68.3%67.9%90.5%71.4%–––––
Employee costs, % of revenue3.7%–5.8%4.1%4.8%5.6%–––––
Other expenses, % of revenue6.8%–12.6%5.6%8.1%7.9%–––––
Depreciation and amortisation0.30.20.20.20.10.10.10.10.10.00.0
Operating profit after depreciation0.73.51.44.3−0.61.2−1.4−1.2−1.3−1.4−1.1
Other income0.20.40.10.50.10.60.31.01.10.90.8
Finance costs0.10.40.50.20.10.00.00.00.00.10.1
Profit before one-off items and tax0.83.61.04.6−0.61.8−1.2−0.2−0.2−0.6−0.4
One-off items––0.00.00.00.00.0−1.20.011.211.2
Profit before tax0.83.61.04.6−0.61.8−1.2−1.3−0.210.510.8
0.21.00.31.1−0.10.4−0.3−0.30.22.52.7
Net profit0.62.60.73.4−0.41.3−0.9−1.0−0.48.08.1
Other comprehensive income––0.00.00.00.0−0.64.0−0.6−1.0−0.9
Total comprehensive income––0.73.4−0.51.3−1.43.0−1.07.07.2
Net margin3.2%7.2%6.0%17.0%−3.2%15.0%–––––
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations2.80.40.75.212.430.833.730.723.1
––1.1––28.2–29.522.2
Materials and goods bought2.50.30.13.913.426.731.027.720.6
Employee costs–––––––0.60.5
Other expenses–––––––1.21.1
Operating profit before depreciation––−0.4––2.6–1.21.0
Operating margin––−61.9%––8.6%–3.9%4.1%
Materials, % of revenue–––––––90.2%89.1%
Employee costs, % of revenue–––––––1.8%2.2%
Other expenses, % of revenue–––––––4.0%4.6%
Depreciation and amortisation0.00.00.00.0–0.3–0.30.3
Operating profit after depreciation––−0.4––2.3–0.90.7
Other income0.20.20.20.20.10.30.20.10.0
Finance costs––0.0–0.01.40.50.40.2
Profit before tax0.40.2−0.30.82.31.20.80.50.5
Tax0.10.10.00.20.80.40.30.10.2
Net profit0.20.2−0.30.61.60.80.50.40.3
Net margin8.7%36.2%−38.5%12.4%12.7%2.6%1.6%1.4%1.5%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 26 MayMar 2024Mar 2025Mar 2026Filed 29 May
8.812.211.713.011.614.613.720.6
Share capital0.20.20.20.20.20.20.20.2
Reserves8.511.911.512.811.414.413.420.4
Borrowings5.82.50.00.00.00.00.00.0
6.34.30.10.20.20.30.20.0
0.10.10.30.10.00.00.00.2
Total assets15.216.612.113.311.814.913.920.9
1.31.21.11.310.612.211.47.9
13.815.411.012.01.32.72.513.0
Net debt5.51.9−8.2−11.8−1.0−0.5−0.9−11.7
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Filed 26 MayMar 2024Mar 2025Mar 2026Filed 29 May
10.63.5−1.6−3.80.2−2.9
10.63.9−1.9−3.70.2−0.9
11.02.3−0.1−2.00.80.1
Receivables11.01.40.00.00.00.0
Inventories0.70.80.00.00.10.0
Payables−0.4−0.20.00.00.0−0.1
Other working capital−0.30.2−0.1−2.00.70.2
Tax paid0.0−0.40.4−0.10.0−2.0
Capital spending0.00.00.00.00.00.0
Free cash flow10.63.4−1.6−3.80.2−2.9
0.00.2−9.33.30.213.7
−2.90.00.00.00.00.0
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash7.63.6−10.9−0.40.410.8
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 26 MayMar 2024Mar 2025Mar 2026Filed 29 May
Earnings per share₹23.93₹104.29₹30.33₹138.89−₹18.25₹53.99−₹36.13−₹41.36−₹16.33₹325.34
Diluted earnings per share₹23.93₹104.29₹30.33₹138.89−₹18.25₹53.99−₹36.13−₹41.36−₹16.33₹325.34
Book value per share––₹358.19₹497.00₹478.04₹532.51₹473.36₹596.74₹557.83₹842.78

Ratios

Standalone, years to March.

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 26 MayMar 2024Mar 2025Mar 2026Filed 29 May
Revenue growth−21.9%96.7%−65.2%62.1%−30.4%−36.7%−100.0%–––
Operating profit growth4.0%282.3%−56.6%172.6%––––––
Net profit growth71.3%336.0%−70.9%358.0%––––––
Earnings per share growth71.7%335.8%−70.9%357.9%––––––
––8.5%32.5%−3.7%10.7%––––
–––24.0 pts−36.2 pts14.4 pts––––
From the net margin–––15.4 pts−38.6 pts21.2 pts––––
From asset turnover–––13.1 pts1.4 pts−5.0 pts––––
From borrowing–––−4.5 pts1.0 pts−1.8 pts––––
Return on capital employed––9.9%29.4%−5.2%9.3%−12.5%−8.2%−9.5%−6.9%
Cash conversion–––––262.2%–––−36.1%
Interest cover11.59.23.218.8–71.1––––
Debt to equity––0.660.210.000.000.000.000.000.00
Receivable days––98226360––––
Inventory days––41442253–1,93,0850–
Payable days––1520010–4,77,0551,069–
Cash conversion cycle, days––49824861−7––––
Working capital days––388236721––––
Asset turnover––0.821.260.970.690.000.000.000.00
Assets per rupee of net worth––1.731.521.201.031.021.021.021.01
Sales per rupee of plant––10.8620.5416.1311.020.000.000.00–
Capital spending to depreciation––––0.170.220.000.000.000.00
Plant being built, % of plant in use––0.0%3.3%3.8%0.0%–0.0%––
Interest cover is left blank for the years to Mar 2021 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
45.8%
Measure10 years5 years3 years
Profit growth, yearly rate37.0%––
Return on capital employed, average–−5.6%−8.2%
Asset turnover, average–0.140.00
Debt to equity, average–0.000.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−4.5−6.4−2.9
Cash from investing8.117.213.7
Cash from financing0.00.00.0
Capital spending0.00.00.0
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid0.00.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––46––––
Beneish M-scorePublished threshold −1.78––––−6.19−5.12––––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−76.86−18.1279.19−4.43−5.34−16.41
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––––––−0.98
Receivables growth less revenue growthOur threshold 0 percentage points–––210.19−58.37−63.29––––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−145.12−37.72−43.74100.00–−52,900.00–
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.87−2.19−4.27––––
Assets under construction, years of additionsOur threshold 2 years of additions–––7.901.170.00–0.00––
Effective tax ratePublished threshold 17.16 per cent28.6228.4328.5225.24–24.98–––24.22
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––2.57–––5.35
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2026 the company reports one business segment which carries all its revenue.

Who owns Triochem Products, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters68.65%
  • Individuals and others31.35%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Individuals and others
68.65%31.35%68.65%31.35%Sep 22Jun 23Mar 24Dec 24Sep 25Sep 26
Per centDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%
Indian promoters68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%68.65%
31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%31.35%
Shares in issue2,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,0002,45,000
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Number of Triochem Products shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

62Dec 1662Mar 1762Jun 1762Sep 1762Dec 1762Mar 1862Jun 1855Sep 1855Dec 1855Mar 1955Jun 1955Sep 1955Dec 1955Mar 2055Jun 2055Sep 2055Dec 2055Mar 2155Jun 2155Sep 2155Dec 2155Mar 2255Jun 2255Sep 2255Dec 2255Mar 2355Jun 2355Sep 2355Dec 2355Mar 2455Jun 2455Sep 2455Dec 2455Mar 2555Jun 2555Sep 2554Dec 2554Mar 2655Jun 2655Sep 26
ShareholdersDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
All shareholders62626262626262555555555555555555555555555555555555555555555555555555555554545555
5555555555555555555555555555555555555555
Indian promoters5555555555555555555555555555555555555555
57575757575757505050505050505050505050505050505050505050505050505050505049495050
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Triochem Products promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is GRACE R DEORA, 14.69%.

Holder
GRACE R DEORAIndividuals and Hindu undivided families14.69%36,000
RAJESH RAMU DEORAIndividuals and Hindu undivided families14.69%36,000
RAMU SITARAM DEORAIndividuals and Hindu undivided families14.08%34,500
RAJIV RAMU DEORAIndividuals and Hindu undivided families13.99%34,270
RAMU MAHABIRPRASAD DEORA HUFIndividuals and Hindu undivided families11.19%27,420
No promoter shares are reported as pledged.

Largest public holders of Triochem Products, filing by filing

Per cent, on the same shares as the split above.

HolderDec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
AMBERNATH PLASTO PACKAGING PRIVATE LIMITEDCompanies4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%
G AMPHRAY PHARMACEUTICALS PRIVATE LIMITEDCompanies4.90%4.90%4.90%4.90%4.90%–4.90%–4.90%4.90%––––––4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%
TRIOCHEM LABORATORIES PRIVATE LIMITEDCompanies4.90%4.90%4.90%4.90%4.90%–––––––––––4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%
PRAVINA NAKUMResident individuals, up to ₹2 lakh at face value–––––––––––––––––––––––––––––––––––2.94%2.94%2.94%2.94%2.94%
MITAL SHRIKANT THAKKERResident individuals, up to ₹2 lakh at face value–––––––––––––––––––––––––––––––––––2.86%2.86%2.86%2.86%2.86%
ALKA BOYEDResident individuals, up to ₹2 lakh at face value–––––––––––––––––––––––––––––––––––2.78%1.96%1.96%1.49%1.49%
BHAGWANTI HASTIMAL JAINResident individuals, up to ₹2 lakh at face value––––––––––––––––––––––––––––––––––––1.22%1.22%1.22%1.22%
SAVITRI NARESHCHANDRA JAINResident individuals, up to ₹2 lakh at face value–––––1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%
SNEHPRABHA AGARWALResident individuals, up to ₹2 lakh at face value–––––1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%
VIMLA S SHARMAResident individuals, up to ₹2 lakh at face value–––––1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%1.02%
RAMESH RAJARAM PATILResident individuals, up to ₹2 lakh at face value–––––––4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%–––––
RAJKUMAR SHRINIWAS BAJORIAResident individuals, up to ₹2 lakh at face value–––––––––––––––––2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%–––––
Rajkumar SarafResident individuals, up to ₹2 lakh at face value2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%2.94%–––––––––––––––––––––––
G AMPHRAY PHARMACEUTICALS PRIVATE LOther non-institutions–––––4.90%–4.90%––4.90%4.90%4.90%4.90%4.90%4.90%––––––––––––––––––––––––
TRIOCHEM LABORATORIES PRIVATE LIMITOther non-institutions–––––4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%4.90%––––––––––––––––––––––––
VIJAYA RANI SARAFResident individuals, up to ₹2 lakh at face value–––––2.55%2.55%–––––––––––––––––––––––––––––––––
VISHWANATH M JHUNJHUNWALAResident individuals, up to ₹2 lakh at face value–––––1.22%1.22%–––––––––––––––––––––––––––––––––
PURSHOTTAMLAL JHUNJHUNWALAResident individuals, up to ₹2 lakh at face value–––––1.00%1.00%–––––––––––––––––––––––––––––––––
MRS VIJAYA RANI SARAFResident individuals, up to ₹2 lakh at face value2.55%2.55%2.55%2.55%2.55%–––––––––––––––––––––––––––––––––––
MR VISHWANATH M JHUNJHUNWALResident individuals, up to ₹2 lakh at face value1.22%1.22%1.22%1.22%1.22%–––––––––––––––––––––––––––––––––––
MRS SAVITRI NARESHCHANDRA JAIResident individuals, up to ₹2 lakh at face value1.02%1.02%1.02%1.02%1.02%–––––––––––––––––––––––––––––––––––
MRS SNEHPRABHA AGARWALResident individuals, up to ₹2 lakh at face value1.02%1.02%1.02%1.02%1.02%–––––––––––––––––––––––––––––––––––
SMT VIMLA S SHARMAResident individuals, up to ₹2 lakh at face value1.02%1.02%1.02%1.02%1.02%–––––––––––––––––––––––––––––––––––
MR PURSHOTTAMLAL JHUNJHUNWALResident individuals, up to ₹2 lakh at face value1.00%1.00%1.00%1.00%1.00%–––––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

Triochem Products share price by year

Each calendar year to 2015.

YearClose at year endChangeHighest closeLowest close
201517.40+5.5%17.4016.80
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2015 is from its first session, 17 Apr 2015. The change in 2015 is on the close at the end of 2012, the last year before it with a trade. The 2015 close is its last trade, on 24 Sep 2015.

Recent sessions

The 10 trading days to 24 Sep 2015, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
24 Sep 201517.4017.4017.4017.4017.405
10 Sep 201517.1017.1017.1017.1017.1010
17 Apr 201516.8016.8016.8016.8016.801
3 Dec 201216.5016.5016.5016.5016.5015
17 Oct 201216.2016.2016.2016.2016.205
10 Oct 201215.8915.8915.8915.8915.895
9 Oct 201215.5815.5815.5815.5815.5810
8 Oct 201215.2815.2815.2815.2815.2810
1 Oct 201214.9914.9914.9914.9914.9910
27 Sep 201214.7014.7014.7014.7014.706,700
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
512101
ISIN
INE331E01013
Industry
Pharmaceuticals & Biotechnology
CIN
L24249MH1972PLC015544
Corporate identity number, the registrar of companies' code for it
Incorporated
1972
Registered office
Sambava Chambers, 4th Floor, Sir P M Road, Fort, Mumbai 400001, Maharashtra
Share registrar
MUFG Intime India Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments